Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Angiology|March 1, 2014
Acute cardiotoxic effects of adjuvant trastuzumab treatment and its relation to oxidative stressAhmet Dirican, Fatih Levent, Ahmet Alacacioglu, et al.
Indian Journal of Cancer|May 24, 2020
An analysis of adjuvant treatment strategies in operated pancreatic cancer patients: An Izmir oncology group studyUmut Varol, Yusuf Uzum, Adem Sengul, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 1, 2015
Adjuvant chemotherapy and prognostic factors in stage II colon cancer--Izmir Oncology Group StudyYuksel Kucukzeybek, Ahmet Dirican, Lutfiye Demir, et al.
Chemotherapy|April 13, 2016
Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group StudyTarik Salman, Seher Nazli Kazaz, Umut Varol, et al.
European Geriatric Medicine|March 12, 2022
The relationship between sarcopenia detected in newly diagnosed colorectal cancer patients and FGF21, irisin and CRP levelsUtku Oflazoglu, Sevinc Caglar, Huriye Erbak Yılmaz, et al.
The Breast Journal|March 29, 2014
Prognostic evaluation of breast cancer patients with evident bone marrow metastasisLutfiye Demir, Murat Akyol, Sadi Bener, et al.
Case Reports in Oncological Medicine|July 15, 2014
Isolated liver metastasis of sacrococcygeal chordoma: case report and review of the literatureMurat Akyol, Umut Varol, Ibrahim Yildiz, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 18, 2013
Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alphaAhmet Dirican, Yuksel Kucukzeybek, Cigdem Erten, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 8, 2014
Treatment of metastatic colorectal cancer with or without bevacizumab: can the neutrophil/lymphocyte ratio predict the efficiency of bevacizumab?Ahmet Dirican, Umut Varol, Yuksel Kucukzeybek, et al.
Cancer Biomarkers : Section a of Disease Markers|June 6, 2013
The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancerAhmet Dirican, Nese Ekinci, Arzu Avci, et al.
Pageof 9